Article 1
Implementing Regulation (EU) No 686/2012 is amended in accordance with Annex I to this Regulation.
Commission Implementing Regulation (EU) 2019/336 of 27 February 2019 amending Regulation (EU) No 1141/2010 and Implementing Regulation (EU) No 686/2012 as regards the rapporteur Member State for the evaluation of 1-methylcyclopropene, famoxadone, mancozeb, methiocarb, methoxyfenozide, pirimicarb, pirimiphos-methyl and thiacloprid (Text with EEA relevance.)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Implementing Regulation (EU) No 686/2012 is amended in accordance with Annex I to this Regulation.
Regulation (EU) No 1141/2010 is amended in accordance with Annex II to this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 30 March 2019. However, where a decision has been taken to extend the two year period referred to in Article 50(3) of the Treaty on European Union, this Regulation shall apply from the day following that on which legislation in the field of plant protection products ceases to apply to and in the United Kingdom.
ANNEX I Part A of the Annex to Implementing Regulation (EU) No 686/2012 is amended as follows: (a) the entry for 1-methyl-cyclopropene is replaced by the following: Active substance Rapporteur Member State Co-rapporteur Member State ‘1-methyl-cyclopropene NL’ (b) the entry for Mancozeb is replaced by the following: Active substance Rapporteur Member State Co-rapporteur Member State ‘Mancozeb EL’ (c) the entry for Methiocarb is replaced by the following: Active substance Rapporteur Member State Co-rapporteur Member State ‘Methiocarb DE’ (d) the entry for Methoxyfenozide is replaced by the following: Active substance Rapporteur Member State Co-rapporteur Member State ‘Methoxyfenozide SK’ (e) the entry for Pirimicarb is replaced by the following: Active substance Rapporteur Member State Co-rapporteur Member State ‘Pirimicarb SE’ (f) the entry for Pirimiphos-methyl is replaced by the following: Active substance Rapporteur Member State Co-rapporteur Member State ‘Pirimiphos-methyl FR’ (g) the entry for Thiacloprid is replaced by the following: Active substance Rapporteur Member State Co-rapporteur Member State ‘Thiacloprid DE’
ANNEX II In Annex I to Regulation (EU) No 1141/2010, the entry for Famoxadone is replaced by the following: Column A Column B Column C Column D ‘Famoxadone 2012 FI 31 August 2012’
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.